Disclosures for "A Pilot Survey Into the Landscape of Neuro-oncology Care in the Community"
-
Dr. Lu-Emerson has received personal compensation in the range of $500-$4,999 for serving as a Member with National Cancer Institute Brain Malignancy Steering Committee.
-
Dr. Chowdhary has received personal compensation for serving as an employee of Merck. Dr. Chowdhary has received personal compensation for serving as an employee of Servier. Dr. Chowdhary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Chowdhary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier.
-
Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kazia Therapeutics, Elekta AB, Viewray Inc, Castle Biosciences, NovoCure Inc., Brainlab, Ion Beam Applications. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viewray Medical Advisory Board, GT Medical Technologies, Insightec Ltd, Plus Therapeutics Inc. Dr. Kotecha has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure. Dr. Kotecha has received research support from Medtronic Inc. Blue Earth Diagnostics NovoCure Inc. GT Medical Technologies AstraZeneca Exelixis Viewray Inc. Brainlab Cantex Pharmaceuticals, Inc. Ion Beam Applications.
-
Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Incyte. The institution of Dr. Sharma has received research support from Novocure. The institution of Dr. Sharma has received research support from Apollomics. The institution of Dr. Sharma has received research support from Curis. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with National Brain Tumor Society. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
-
Dr. Odia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
-
Dr. Vaillant has nothing to disclose.
-
Dr. Redfern has received personal compensation in the range of $0-$499 for serving as a Consultant with Medical Board of California.
-
Author has nothing to disclose
-
Dr. Shih has nothing to disclose.
-
Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.
-
Author has nothing to disclose
-
Dr. Friday has nothing to disclose.
-
Dr. Edenfield has nothing to disclose.
-
Dr. Koga has received intellectual property interests from a discovery or technology relating to health care. Dr. Koga has received intellectual property interests from a discovery or technology relating to health care.
-
The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. The institution of Dr. Snyder has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Premier Applied Sciences. The institution of Dr. Snyder has received research support from Vizilitics inc.
-
Dr. JABOIN has nothing to disclose.
-
Dr. Melguizo-Gavilanes has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Humeniuk has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Dunbar has nothing to disclose.